Dr. Reddy's Laboratories Limited annual net income for fiscal 2026 was $42.9 billion, a decrease of 24.2% from $56.5 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Net Income | $42.9B | $56.5B | $55.7B | $45.1B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Net Income | $2.2B | $12.1B | $14.4B | $14.2B | $15.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources